Ascletis Pharma has reported positive topline outcomes from its US Phase Ia single ascending dose (SAD) study of the oral ...

The best tablets are used for a variety of reasons, but they're especially perfect for note taking. These devices are a digital alternative to pen and paper, making it easier than ever for ...

This real‐world study compared health care resource use (HRU) and costs for rivaroxaban and warfarin in patients with NVAF who had polypharmacy and obesity. We used health care claims databases ...

Amazon’s Fire tablets are some of the cheapest slates you can buy, and the Amazon Fire 7 is the least expensive yet.It’s not the best performer, but for the $60 asking price (or $75 if you ...

Scheduled for 13 weeks, the trial will assess the therapy’s safety, tolerability, and efficacy in weight loss.

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.

Here’s how it works. While you might think that, between your smartphone and your laptop, phone and ereader, all your needs are covered, but the best tablets on the market offer an impressive ...

If you want a great Android tablet, you should be considering Samsung. I say that because I think Samsung makes some of the best Android tablets on the market. My team and I have reviewed so many ...

“Prior 28-day Phase 1 data demonstrated encouraging tolerability with the tablet formulation ... for the treatment of obesity and other metabolic disorders. In the rare disease space, Viking is ...

Gaming tablets offer more than just a screen for play. These devices need to juggle productivity features and entertainment options to make their prices worthwhile, all while still offering a high ...

13-Week Study to Evaluate the Safety and Efficacy of Oral VK2735 Dosed Once Daily SAN DIEGO, Jan. 8, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage ...

"Prior 28-day Phase 1 data demonstrated encouraging tolerability with the tablet formulation ... sensitivity in patients with type 2 diabetes, obesity, or both. Semaglutide is a GLP-1 receptor ...